Vivani Medical & Okava Pharmaceuticals Extend Collaboration to Develop OKV-119 for Canine Cardiometabolic Diseases

Shots:Vivani Medical & Okava Pharmaceuticals have expanded their 2019 collaboration to develop OKV-119 for cardiometabolic conditions in dogs, which initially focused on catsFinancial terms of the expanded agreement remain undisclosed but incl. future milestones & royalty payments to VivaniOKV-119 (GLP-1 receptor agonists) uses Vivani’s NanoPortal tech for steady drug delivery over time from…

ByRidhi RastogiApril 16, 2025

NEWS

GumPaws Launches Gummy Supplements to Promote Dental Health in Dogs

Shots:GumPaws has launched gummy supplements to support dental health in dogs GumPaws gummies are designed with specific density & chewiness to improve friction, helping clean plaque & support dental care in dogs, offering dual-benefit compared to conventional supplements Gummies are formulated with scientifically-backed natural ingredients that start absorbing through the gums &…

ByRidhi RastogiMarch 7, 2025

Vivani Medical & Okava Pharmaceuticals Extend Collaboration to Develop OKV-119 for Canine Cardiometabolic Diseases

GumPaws Launches Gummy Supplements to Promote Dental Health in Dogs

Contact US

OUR INFORMATION

FOLLOW US